About the Virtual Congress

FREE REGISTRATION
*

Under the leadership of our tremendous program chairs, Dr. Bill Kelly and Dr. Girolamo Pelaia, and our partnership with the CHEST Italian Delegation, led by Professor Francesco de Blasio, more than 3000 people joined our 1-day, educational congress on June 26, 2020, focusing on the most recent discoveries on COVID-19, pulmonary, critical care, and sleep medicine; and more!

Now you can access all the content including concise updates on a range of topics, a recording of our live COVID-19 panel discussion , downloadable handouts, all the accepted E-Poster presentations from the CHEST Congress in Bologna which is now postponed until June 2021.

We are sure you will find this content extremely relevant during this difficult time where our work, personal, and social lives are so disrupted.

Register for free and access the content as much as you would like up until September 26, 2020.

View the content from the 1-day CHEST Virtual Congress 2020 and claim five CME credits. All delegates who participated in the live event on June 26 will receive an email in July with instructions on how to claim credits. Anyone completing the course materials after June 26 will be able to claim credits after September 26, 2020.

Why Participate

The virtual program will help you stay up to date on the latest advancements in the field.

Learn

Understand the core of the matter quickly
in these concise sessions.

CME Accredited

Earn up to 5 CME/CE credits by
attending sessions

Free Registration

Access all the scientific information
on demand for free.

Our Speakers

Meet the specialists in pulmonary, critical care, and sleep medicine that will lead the Virtual Congress.

Supported in part by an educational grant from Elsevier, publisher of the journal CHEST.

What’s on Offer

Moderators: William F. Kelly, MD, FCCP, Girolamo Pelaia, MD, FCCP and Francesco de Blasio, MD, FCCP

Panelists:
Stefano Nava, MD,
Semra Bilaceroglu, MD,
Mangala Narasimhan, DO, FCCP

Learning Objectives:
• Share with the panel for their awareness and comment, if desired.
• Appraise investigational and repurposed therapeutic agents in development for treating COVID-19 infection.
• Recognize differences in epidemiology related to outcomes across three international regions.
• Identify best methods to protect against COVID-19 transmission.

Gerard A. Silvestri, MD, FCCP

Learning Objectives
• Define the epidemiology of this disorder.
• Review the diagnostic approach to distinguishing benign from malignant disease.
• Better understand when to use lung biopsy, PET scan, or surgery for the management of lung nodules.
• Introduce how blood biomarkers will potentially be used in this space.

Sandhya Khurana, MD, FCCP

Learning Objectives
• Discuss recent advances in the understanding of pathobiology of asthma.
• List available asthma biomarkers and their role in pheno-endotyping.
• Review targeted treatment options in severe asthma.

Sergio Harari, MD

Learning Objectives
• Provide a change of perspective for COVID-19 infection and ILD.
• Review pulmonary fibrosis after COVID-19 disease.
• Describe common approaches to COVID-19 disease and ILD.

Neil S. Freedman, MD, FCCP

Session Description
Obesity hypoventilation syndrome (OHS) is a relatively common cause of chronic hypercapnic respiratory failure and can occur with or without obstructive sleep apnea, yet the optimal approach to treatment is not well defined. This will be a case-based interactive session that will review current diagnostic criteria, recent literature and guidelines, and various management strategies. During this session, the faculty and attendees will also review the role of CPAP and more advanced nocturnal ventilatory modalities on outcomes in patients with OHS.
Learning Objectives
• Define obesity hypoventilation syndrome (OHS) and diagnostic approaches.
• Understand the most recent literature and guidelines related to the management of OHS.
• List different management strategies, including the use of various nocturnal ventilatory modes, that may improve outcomes in this patient population.

Steven Q. Simpson, MD, FCCP

Learning Objectives
• Discuss the longer-term implications of a sepsis hospitalization.
• Apply SV-based volume resuscitation for septic patients.
• Treat sepsis early in its course, and aggressively.

Bartolome R. Celli, MD, FCCP

Learning Objectives
• Describe the COPD landscape in the USA and the world.
• Provide a practical approach to initiate and modify pharmacotherapy in patients with COPD.
• Review the tools available for patients receiving maximal therapy who remain functionally impaired.

Lisa K. Moores, MD, FCCP
Learning Objectives
• Review the pathophysiology of VTE and how this manifests in patients with COVID-19.
• Discuss optimal methods of prophylaxis.
• Apply recently published guidelines to the management of patients with COVID-19.

Otis Rickman, DO, FCCP
Learning Objectives
• Understand how to safely perform bronchoscopy in patients with COVID-19.
• List aerosol-generating pulmonary procedures.
• Minimize COVID-19 infection risk when performing percutaneous tracheostomy.

Experience CHEST

Visit our Experience CHEST page to see the resources and opportunities CHEST offers for updating knowledge and advancing careers.

Experience CHEST

Free Registration

Fill out the form and join us online for the CHEST 2020 Virtual Congress.

*